Astrana Health, Inc. (ASTH)
NASDAQ: ASTH · Real-Time Price · USD
41.04
+0.11 (0.27%)
Nov 20, 2024, 4:00 PM EST - Market closed
Astrana Health Market Cap
Astrana Health has a market cap or net worth of $2.02 billion as of November 21, 2024. Its market cap has increased by 19.16% in one year.
Market Cap
2.02B
Enterprise Value
1.94B
1-Year Change
19.16%
Ranking
Category
Stock Price
$41.04
Market Cap Chart
Since December 8, 2017, Astrana Health's market cap has increased from $60.30M to $2.02B, an increase of 3,243.09%. That is a compound annual growth rate of 65.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 2.31B | 3.42% |
| Dec 29, 2023 | 2.23B | 33.00% |
| Dec 30, 2022 | 1.68B | -58.88% |
| Dec 31, 2021 | 4.08B | 311.71% |
| Dec 31, 2020 | 991.40M | 54.33% |
| Dec 31, 2019 | 642.40M | -5.05% |
| Dec 31, 2018 | 676.60M | 367.27% |
| Dec 29, 2017 | 144.80M | 140.13% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Premier | 2.14B |
| Amphastar Pharmaceuticals | 2.12B |
| Ligand Pharmaceuticals | 2.11B |
| Mirum Pharmaceuticals | 2.10B |
| Azenta | 2.03B |
| Supernus Pharmaceuticals | 1.99B |
| Tandem Diabetes Care | 1.98B |
| NeoGenomics | 1.97B |